< Back to previous page

Publication

Novel human-derived EML4-ALK fusion cell lines identify ribonucleotide reductase RRM2 as a target of activated ALK in NSCLC

Journal Contribution - Journal Article

Journal: LUNG CANCER

ISSN: 1872-8332

Volume: 171

Pages: 103 - 114

Publication year:2022

WoS Id: 000931816200010
DOI: https://doi.org/10.1016/j.lungcan.2022.07.010
Handle: http://hdl.handle.net/1854/LU-01GK1A8SW2N3K7521ZJ5C8F8NH

Accessibility:Open